237 related articles for article (PubMed ID: 21323111)
1. Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging.
Mendoza-Sánchez AN; Ferro-Flores G; Ocampo-García BE; Morales-Avila E; de M Ramírez F; De León-Rodríguez LM; Santos-Cuevas CL; Medina LA; Rojas-Calderón EL; Camacho-López MA
J Biomed Nanotechnol; 2010 Aug; 6(4):375-84. PubMed ID: 21323111
[TBL] [Abstract][Full Text] [Related]
2. Kit for preparation of multimeric receptor-specific ⁹⁹mTc-radiopharmaceuticals based on gold nanoparticles.
Ocampo-García B; Ferro-Flores G; Morales-Avila E; Ramírez Fde M
Nucl Med Commun; 2011 Nov; 32(11):1095-104. PubMed ID: 21860334
[TBL] [Abstract][Full Text] [Related]
3. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
Ferro-Flores G; Arteaga de Murphy C; Rodriguez-Cortés J; Pedraza-López M; Ramírez-Iglesias MT
Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells.
Jiménez-Mancilla N; Ferro-Flores G; Santos-Cuevas C; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Isaac-Olivé K; Camacho-López M; Torres-García E
J Labelled Comp Radiopharm; 2013 Nov; 56(13):663-71. PubMed ID: 25196028
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands].
Hernández-Cairo A; Perera-Pintado A; Prats-Capote A; Batista-Cuellar JF; Casacó-Santana C
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):61-5. PubMed ID: 22305264
[TBL] [Abstract][Full Text] [Related]
7. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
[TBL] [Abstract][Full Text] [Related]
8. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Pichardo-Romero PA
Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
[TBL] [Abstract][Full Text] [Related]
10. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X
J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619
[TBL] [Abstract][Full Text] [Related]
11. Improved radiopharmaceutical based on 99mTc-Bombesin-folate for breast tumour imaging.
Aranda-Lara L; Ferro-Flores G; Ramírez Fde M; Ocampo-García B; Santos-Cuevas C; Díaz-Nieto L; Isaac-Olivé K
Nucl Med Commun; 2016 Apr; 37(4):377-86. PubMed ID: 26657220
[TBL] [Abstract][Full Text] [Related]
12. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
13. Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging.
Orocio-Rodríguez E; Ferro-Flores G; Santos-Cuevas CL; Ramírez Fde M; Ocampo-García BE; Azorín-Vega E; Sánchez-García FM
J Nanosci Nanotechnol; 2015 Jun; 15(6):4159-69. PubMed ID: 26369025
[TBL] [Abstract][Full Text] [Related]
14. A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation.
Lin KS; Luu A; Baidoo KE; Hashemzadeh-Gargari H; Chen MK; Brenneman K; Pili R; Pomper M; Carducci MA; Wagner HN
Bioconjug Chem; 2005; 16(1):43-50. PubMed ID: 15656574
[TBL] [Abstract][Full Text] [Related]
15. (99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.
Ananias HJ; Yu Z; Dierckx RA; van der Wiele C; Helfrich W; Wang F; Yan Y; Chen X; de Jong IJ; Elsinga PH
Mol Pharm; 2011 Aug; 8(4):1165-73. PubMed ID: 21699202
[TBL] [Abstract][Full Text] [Related]
16. Clinical translation of a PSMA inhibitor for
Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO
Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
[TBL] [Abstract][Full Text] [Related]
17. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity.
Chanda N; Kattumuri V; Shukla R; Zambre A; Katti K; Upendran A; Kulkarni RR; Kan P; Fent GM; Casteel SW; Smith CJ; Boote E; Robertson JD; Cutler C; Lever JR; Katti KV; Kannan R
Proc Natl Acad Sci U S A; 2010 May; 107(19):8760-5. PubMed ID: 20410458
[TBL] [Abstract][Full Text] [Related]
18. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
[TBL] [Abstract][Full Text] [Related]
19. Engineered multifunctional RGD-gold nanoparticles for the detection of tumour-specific alpha(v)beta(3) expression: chemical characterisation and ecotoxicological risk assessment.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; Gómez-Oliván LM
J Biomed Nanotechnol; 2012 Dec; 8(6):991-9. PubMed ID: 23030007
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]